Mesa Laboratories Inc
MLAB80.470USD
-0.200-0.25%
Handelsschluss 12/26, 16:00（ET）Kurse um 15 Minuten verzögert
443.45MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Mesa Laboratories Inc Unternehmen
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Mesa Laboratories Inc Informationen
BörsenkürzelMLAB
Name des UnternehmensMesa Laboratories Inc
IPO-datumFeb 29, 1984
CEOOwens (Gary M)
Anzahl der mitarbeiter730
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 29
Addresse12100 W 6th Ave
StadtLAKEWOOD
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80228
Telefon13039878000
Websitehttps://mesalabs.com
BörsenkürzelMLAB
IPO-datumFeb 29, 1984
CEOOwens (Gary M)
Führungskräfte von Mesa Laboratories Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Nach RegionUSD
Name
Umsatz
Anteil
United States
27.65M
46.43%
Other
26.47M
44.45%
China
5.43M
9.12%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Andere
73.26%
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Andere
73.26%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
37.82%
Investment Advisor/Hedge Fund
35.41%
Hedge Fund
13.57%
Individual Investor
5.44%
Research Firm
4.14%
Bank and Trust
0.88%
Pension Fund
0.84%
Sovereign Wealth Fund
0.06%
Insurance Company
0.03%
Andere
1.82%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
387
5.12M
92.75%
-722.23K
2025Q2
399
5.60M
101.85%
-541.53K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Conestoga Capital Advisors, LLC
566.15K
10.29%
-5.21K
-0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
708.66K
12.88%
-30.52K
-4.13%
Jun 30, 2025
The Vanguard Group, Inc.
388.10K
7.05%
+4.80K
+1.25%
Jun 30, 2025
Ranger Investment Management, L.P.
214.29K
3.9%
-16.70K
-7.23%
Jun 30, 2025
Geneva Capital Management LLC
199.09K
3.62%
+9.78K
+5.17%
Jun 30, 2025
Royce Investment Partners
247.61K
4.5%
-23.51K
-8.67%
Jun 30, 2025
Owens (Gary M)
136.70K
2.48%
+13.43K
+10.89%
Jun 21, 2025
Janus Henderson Investors
113.28K
2.06%
+32.54K
+40.30%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
145.94K
2.65%
-1.85K
-1.25%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
VictoryShares Small Cap Free Cash Flow ETF
0.22%
Principal U.S. Small-Cap ETF
0.1%
Vanguard US Quality Factor ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Fund
0.05%
Avantis US Small Cap Equity ETF
0.05%
WisdomTree U.S. SmallCap Dividend Fund
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Mehr Anzeigen
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.22%
Principal U.S. Small-Cap ETF
Anteil0.1%
Vanguard US Quality Factor ETF
Anteil0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.06%
WisdomTree US SmallCap Fund
Anteil0.05%
Avantis US Small Cap Equity ETF
Anteil0.05%
WisdomTree U.S. SmallCap Dividend Fund
Anteil0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
16.82M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 15, 2025
Nov 28, 2025
Jul 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
Apr 07, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025
May 30, 2025
Jun 16, 2025
May 30, 2025
Jan 08, 2025
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Mesa Laboratories Inc?
Die fünf größten Anteilseigner von Mesa Laboratories Inc sind:
Conestoga Capital Advisors, LLC hält 566.15K Aktien, was 10.29% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 708.66K Aktien, was 12.88% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 388.10K Aktien, was 7.05% der Gesamtaktien entspricht.
Ranger Investment Management, L.P. hält 214.29K Aktien, was 3.90% der Gesamtaktien entspricht.
Geneva Capital Management LLC hält 199.09K Aktien, was 3.62% der Gesamtaktien entspricht.
Conestoga Capital Advisors, LLC hält 566.15K Aktien, was 10.29% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 708.66K Aktien, was 12.88% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 388.10K Aktien, was 7.05% der Gesamtaktien entspricht.
Ranger Investment Management, L.P. hält 214.29K Aktien, was 3.90% der Gesamtaktien entspricht.
Geneva Capital Management LLC hält 199.09K Aktien, was 3.62% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Mesa Laboratories Inc?
Die drei wichtigsten Anteilseigner-Typen von Mesa Laboratories Inc sind:
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Wie viele Institutionen halten Anteile an Mesa Laboratories Inc (MLAB)?
Mit Stand vom 2025Q3 halten 387 Institutionen Anteile an Mesa Laboratories Inc, mit einem Gesamtmarktwert von etwa 5.12M, was 92.75% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -9.10% gestiegen.
Was ist die größte Einnahmequelle von Mesa Laboratories Inc?
Am FY2026Q1 erzielte das Geschäft mit Discrete Revenues- Consumables für Mesa Laboratories Inc den höchsten Umsatz in Höhe von 35.77M, was 60.08% des Gesamtumsatzes entspricht.
